spacer
The Healthcare Sales & Marketing Network celebrates 28 years serving the medical sales & marketing community.Connecting Medical Sales Reps with MedTech/BioPharma Recruiters and Independent Reps with and New Product LinesConnecting Medical Sales Reps with MedTech/BioPharma Recruiters and Independent Reps with and New Product Lines

Healthcare Industry NewsFeed

 HSMN NewsFeed - 4 Apr 2017
Collegium Announces Appointment of Steven Passik, PhD, as Vice President, Scientific Affairs, Education and Policy
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 4 Apr 2017
NantKwest and Viracta Therapeutics Announce Series B Financing and Immunotherapy Partnership
Biopharmaceuticals Oncology Venture Capital Personnel
 HSMN NewsFeed - 4 Apr 2017
AMAG Pharmaceuticals Announces Closing of Exclusive Licensing Agreement With Endoceutics for U.S. Rights to Intrarosa(TM) (Prasterone)
Biopharmaceuticals Licensing
 HSMN NewsFeed - 4 Apr 2017
Relay Therapeutics Appoints Pharmaceutical Leader Sanjiv K. Patel, M.D. to President and Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 4 Apr 2017
Synchron Inc. Secures $10 Million in Series A Financing Round
Devices Neurology Venture Capital
 HSMN NewsFeed - 4 Apr 2017
Teva Announces FDA Approval of AUSTEDO(TM) (deutetrabenazine) Tablets for the Treatment of Chorea Associated with Huntington’s Disease
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 3 Apr 2017
Retrospective Study Confirms Bovine Carotid Artery Biologic Graft Outperforms Expanded Polytetrafluoroethylene for Hemodialysis Access
Devices Surgery
 HSMN NewsFeed - 3 Apr 2017
MEI Pharma Announces Appointment of Brian Drazba as Chief Financial Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 3 Apr 2017
aTyr Pharma Announces Appointment of Jeffery S. Hatfield to its Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 3 Apr 2017
Atara Bio Expands Management Team, Appoints Joe Newell as Executive Vice President, Chief Technical Operations Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 3 Apr 2017
BioCryst Announces Mundipharma Receives Approval for Mundesine(R) in Japan
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 3 Apr 2017
Sucampo Acquires Vtesse Inc.
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 3 Apr 2017
Astellas to Acquire Ogeda SA
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 31 Mar 2017
Astellas Announces New President of Astellas US Technologies, Inc.
Biopharmaceuticals Personnel
 HSMN NewsFeed - 31 Mar 2017
Novelion Therapeutics Appoints Mark Corrigan, M.D. to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 31 Mar 2017
Vencerx Therapeutics Announces Appointments of Robert H. Ring, Ph.D. as Chief Executive Officer and Jeffrey Stevenson as Chairman of the Board
Biopharmaceuticals Personnel
 HSMN NewsFeed - 31 Mar 2017
Corindus Announces First Robotic-Assisted PCI Procedures Performed in Asia Using CorPath(R) GRX System
Devices Interventional Cardiology
 HSMN NewsFeed - 31 Mar 2017
Osiris Therapeutics Launches Prestige(TM) Lyotechnology, a Novel Method for Ambient Storage of Living Cells and Tissues
Regenerative Medicine Product Launch
 HSMN NewsFeed - 30 Mar 2017
CytomX Therapeutics Appoints Marion McCourt to Board of Directors
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 30 Mar 2017
Bausch & Lomb ULTRA(R) for Astigmatism Contact Lenses Introduced
Devices Ophthalmology Product Launch
 HSMN NewsFeed - 30 Mar 2017
U.S. FDA Approves Addition of Moderate to Severe Fingernail Psoriasis Data to AbbVie's HUMIRA(R) (adalimumab) Prescribing Information
Biopharmaceuticals FDA
 HSMN NewsFeed - 30 Mar 2017
Third Rock Ventures Launches Tango Therapeutics with $55 Million Series A Investment
Biopharmaceuticals Oncology Personnel Venture Capital
 HSMN NewsFeed - 30 Mar 2017
Symetis and Boston Scientific Reach USD 435 Million Purchase Agreement
Devices Interventional Cardiology Mergers & Acquisitions
 HSMN NewsFeed - 30 Mar 2017
Boston Scientific Announces Agreement to Acquire Symetis
Devices Interventional Cardiology Mergers & Acquisitions
 HSMN NewsFeed - 29 Mar 2017
CardioFocus(R) Completes $20 Million Equity Financing
Devices Cardiology Venture Capital
 HSMN NewsFeed - 29 Mar 2017
Tyme Technologies Announces Two New Board of Director Appointments -- David Carberry and James Biehl
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 29 Mar 2017
Tepha Inc. Subsidiary, Galatea Surgical, Announces Launch of GalaSHAPE(TM) 3D Surgical Scaffold
Devices Surgery Product Launch
 HSMN NewsFeed - 29 Mar 2017
Sonoma Pharmaceuticals Receives U.S. FDA Clearance of Loyon(R) Skin Descaler for Relief of Scaling Associated with Various Dermatoses
Biopharmaceuticals Dermatology FDA
 HSMN NewsFeed - 29 Mar 2017
FDA Approves Genentech’s OCREVUS(TM) (Ocrelizumab) for Relapsing and Primary Progressive Forms of Multiple Sclerosis
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 28 Mar 2017
Mylan Names Former SEC Commissioner Daniel Gallagher as Chief Legal Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 28 Mar 2017
Sanofi and Regeneron Announce FDA Approval of Dupixent(R) (dupilumab), the First Targeted Biologic Therapy for Adults with Moderate-to-Severe Atopic Dermatitis
Biopharmaceuticals Dermatology FDA
 HSMN NewsFeed - 28 Mar 2017
Introducing PROMETHEUS(R) IBcause(TM): Convenient All-in-One Diagnostic Test for Persistent Diarrhea
Diagnostics Gastroenterology Product Launch
 HSMN NewsFeed - 28 Mar 2017
ONL Therapeutics Strengthens Leadership with Addition to Board of Directors and Expansion of Operations Team
Biopharmaceuticals Ophthalmology Personnel
 HSMN NewsFeed - 28 Mar 2017
Antiva Biosciences Closes $22 Million Series C Financing
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 28 Mar 2017
Nuvo Pharmaceuticals(TM) Enters into Pennsaid(R) 2% License Agreement with Sayre Therapeutics PVT Ltd. for India, Sri Lanka, Bangladesh and Nepal
Biopharmaceuticals Licensing
 HSMN NewsFeed - 28 Mar 2017
Akcea Therapeutics Announces Three Additions to Board of Directors
Biopharmaceuticals Cardiology Personnel
 HSMN NewsFeed - 28 Mar 2017
Personal Genome Diagnostics' Expanded PlasmaSELECT(TM) 64 Is First Liquid Biopsy Pan-Cancer Profiling Panel to Include MSI Analyses for Immuno-Oncology
Diagnostics Oncology Product Launch
 HSMN NewsFeed - 27 Mar 2017
Bracco Diagnostics Inc. announces the launch of the PROTOCO2L TOUCH(R) Colon Insufflator for use in CT Colonography procedures
Devices Radiology Oncology Product Launch
 HSMN NewsFeed - 27 Mar 2017
Twist Bioscience Raises $33 Million
Biopharmaceuticals Diagnostics Venture Capital
 HSMN NewsFeed - 27 Mar 2017
Bovie Medical Receives 510K Clearance for Its Cool-Coag(TM) Generator and Open Handpiece
Devices Surgery FDA
 HSMN NewsFeed - 27 Mar 2017
Bridge Medicines Appoints William J. Polvino, M.D., As Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 27 Mar 2017
Dr. Reddy’s and Integra LifeSciences Enter into an Agreement to Market and Distribute DuraGen Plus(R) and Suturable DuraGen(R) Dural Regeneration in India
Devices Regenerative Medicine Neurosurgery Distribution
 HSMN NewsFeed - 27 Mar 2017
Dinutuximab beta receives positive recommendation for the treatment of high-risk neuroblastoma in Europe
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 27 Mar 2017
Syneron Candela Announces CE Mark for CO2RE(R) Intima
Devices Regulatory
 HSMN NewsFeed - 24 Mar 2017
Richard Peterson Joins Sienna Biopharmaceuticals As Chief Financial Officer
Biopharmaceuticals Dermatology Personnel
 HSMN NewsFeed - 24 Mar 2017
Reata Pharmaceuticals, Inc. Appoints David Chapman as Vice President, Marketing
Biopharmaceuticals Personnel
 HSMN NewsFeed - 24 Mar 2017
Surgery Without the Knife: Mirabilis Medical Announces European Approval for Non-Invasive Uterine Fibroid Treatment
Devices Regulatory
 HSMN NewsFeed - 24 Mar 2017
FDA Grants Approval for BAVENCIO(R) (avelumab), the First Immunotherapy Approved for Metastatic Merkel Cell Carcinoma
Biopharmaceuticals Oncology FDA Product Launch
 HSMN NewsFeed - 23 Mar 2017
Revolutionary UroLift(R) System Launches in Ireland
Devices Urology Product Launch
 HSMN NewsFeed - 23 Mar 2017
Tyme Appoints Ben Taylor as President and Chief Financial Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 23 Mar 2017
410 Medical Closes $3.3 Million Initial Investment in Series A Financing
Devices Venture Capital
 HSMN NewsFeed - 23 Mar 2017
GE Healthcare to Offer a More Comfortable Mammography Experience
Devices Radiology Product Launch
 HSMN NewsFeed - 23 Mar 2017
Exact Imaging Introduces New FusionVu(TM) micro-US/MRI Fusion to Complement its ExactVu(TM) Micro-Ultrasound System for Prostate Imaging and Biopsy
Devices Urology Product Launch
 HSMN NewsFeed - 23 Mar 2017
New England Journal of Medicine Publishes Pivotal Phase III Data for CSL Behring's Subcutaneous C1-Esterase Inhibitor in HAE Patients
Biopharmaceuticals
 HSMN NewsFeed - 22 Mar 2017
Moleculin Receives Orphan Drug Designation for Annamycin for the Treatment of Acute Myeloid Leukemia
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 22 Mar 2017
BioStable Science & Engineering Announces FDA Clearance of the HAART(TM) 300 Aortic Annuloplasty Device
Devices Cardiology FDA
 HSMN NewsFeed - 22 Mar 2017
Motus GI Appoints Samuel R. Nussbaum, M.D., to Board of Directors
Devices Gastroenterology Oncology Personnel
 HSMN NewsFeed - 22 Mar 2017
AntriaBio Appoints Two Pharmaceutical Executives to its Board of Directors
Biopharmaceuticals Endocrinology Personnel
 HSMN NewsFeed - 22 Mar 2017
Allergan Announces Availability of RESTASIS MULTIDOSE(TM) (Cyclosporine Ophthalmic Emulsion) 0.05% -- the First FDA-Approved Preservative Free Prescription Eye Drop Available in a Multidose Bottle
Biopharmaceuticals Ophthalmology Product Launch
More stories   Return to NewsFeed  
FindReps - screen and connect with rep candidates anonymously, in real time.

FindReps: Screen and connect with Medical Sales Rep candidates (Direct Reps and Independents) – anonymously, in real time.


RepJobs - Job Opportunities for Direct Sales Reps and New Product Lines for Independents!

RepJobs: Job Opportunities for Direct Sales Reps and New Product Lines for Independents!